- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
7 result(s) found for: Metolazone.
Displaying page 1 of 1.
EudraCT Number: 2022-003314-37 | Sponsor Protocol Number: CCM1862 | Start Date*: 2023-04-19 | |||||||||||
Sponsor Name:CENTRO CARDIOLOGICO SPA FONDAZIONE MONZINO | |||||||||||||
Full Title: Effects of combined diuretic therapy on exercise capacity, alveolus-capillary diffusion, and maintenance of euvolemia in chronic congestive heart failure, diuretic therapy compared between loop diu... | |||||||||||||
Medical condition: congestive heart failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-004832-48 | Sponsor Protocol Number: GN19CA407 | Start Date*: 2020-12-17 | ||||||||||||||||||||||||||
Sponsor Name:NHS Greater Glasgow and Clyde [...] | ||||||||||||||||||||||||||||
Full Title: DAPA-RESIST - Sodium glucose cotransporter-2 inhibitor DAPAgliflozin versus thiazide diuretic in patients with heart failure and diuretic RESISTance: a multi-centre, open-label, randomised controll... | ||||||||||||||||||||||||||||
Medical condition: Diuretic resistant heart failure | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-006843-29 | Sponsor Protocol Number: CKI-303 | Start Date*: 2007-06-13 | |||||||||||
Sponsor Name:NovaCardia Inc | |||||||||||||
Full Title: A multicentre, randomized, double-blind, placebo controlled study of the effects of KW-3902 Injectable Emulsion on heart failure signs and symptoms, diuresis, renal function, and clinical outcomes ... | |||||||||||||
Medical condition: Patients being admitted to hospital with heart failure and volume overload requiring IV therapy after experiencing worsening of renal function. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) IT (Completed) PL (Completed) GR (Completed) BE (Completed) GB (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-001407-37 | Sponsor Protocol Number: CKI- 301 | Start Date*: 2007-06-20 | |||||||||||
Sponsor Name:NovaCardia Inc (wholly owned subsidiary of Merck & Co. Inc) | |||||||||||||
Full Title: A multicentre, randomised, double-blind, placebo-controlled study of the effects of KW-3902 Injectable Emulsion on heart failure signs and symptoms and renal function in subjects with acute heart f... | |||||||||||||
Medical condition: Patients being admitted to hospital for acute heart failure (AHFS) with volume overload and renal impairment. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) GB (Completed) CZ (Completed) HU (Completed) IT (Completed) NL (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-001637-18 | Sponsor Protocol Number: CKI- 302 | Start Date*: 2006-11-13 | |||||||||||
Sponsor Name:NovaCardia Inc (wholly owned subsidiary of Merck & Co. Inc) | |||||||||||||
Full Title: A multicentre, randomised, double-blind, placebo-controlled study of the effects of KW-3902 Injectable Emulsion on heart failure signs and symptoms and renal function in subjects with acute heart f... | |||||||||||||
Medical condition: Patients being admitted to hospital for acute heart failure (AHFS) with volume overload and renal impairment. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) FI (Completed) CZ (Completed) BE (Completed) DK (Prematurely Ended) GB (Completed) HU (Completed) DE (Completed) NL (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-006237-27 | Sponsor Protocol Number: CT/P004/HF/08/02_01 | Start Date*: 2009-10-12 | |||||||||||
Sponsor Name:Torrent Pharmaceuticals Ltd. | |||||||||||||
Full Title: Safety and efficacy of TRC4186 in the treatment of stable heart failure associated with HbA1c >= 6 % or type 2 diabetes receiving oral hypoglycaemic therapy (with or without additional insulin) as ... | |||||||||||||
Medical condition: heart failure associated with impaired glucose tolerance or type 2 diabetes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-004670-25 | Sponsor Protocol Number: CQ-001-19 | Start Date*: 2022-11-16 | |||||||||||
Sponsor Name:Corequest sagl | |||||||||||||
Full Title: Peritoneal Ultrafiltration in cardio Renal syndrome to prevent heart failure Exacerbation: The PURE Study | |||||||||||||
Medical condition: Congestive Heart Failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.